Articles | EuroIntervention

Editorial

10.4244/EIJ-D-26-00175 • Mar 2, 2026

Adopting an intravascular imaging-guided management strategy for patients presenting with acute coronary syndrome: from understanding the mechanism to treatment optimisation

Mintz G, Collet C

free

Editorial

10.4244/EIJ-E-26-00001 • Mar 2, 2026

Privileged witnesses: how interventional cardiologists can validate experimental evidence in practice

Escaned J, de Waard G

free

Editorial

10.4244/EIJ-D-26-00106 • Mar 2, 2026

Getting lost – and found – in revascularising chronic limb-threatening ischaemia

Musialek P, Micari A

free

Viewpoint

10.4244/EIJ-D-25-00807 • Mar 2, 2026

Excimer laser coronary atherectomy in contemporary PCI

Jurado-Román A, Basile M

free

Expert Review

10.4244/EIJ-D-25-00250 • Mar 2, 2026

Non-invasive and invasive diagnostic modalities for the assessment of coronary vasomotor dysfunction in ANOCA patients

Bijloo I, Woudstra J, Aribas E, Elias-Smale S, Vink C, Piek J, Duncker D, Roeters van Lennep J, Kavousi M, Appelman Y

free

Original Research

10.4244/EIJ-D-25-01092 • Mar 2, 2026

Intravascular imaging-guided percutaneous coronary intervention in patients with acute coronary syndrome

Takegawa K, Kanaoka K, Iwanaga Y, Sasano T, Nishioka Y, Myojin T, Noda T, Imamura T, Miyamoto Y

Original Research

10.4244/EIJ-D-25-00784 • Mar 2, 2026

Changes in absolute coronary blood flow and myocardial resistance after percutaneous coronary intervention

Marin F, Fawaz S, Kotronias R, Chai J, Walsh J, Mahendiran T, Karamasis G, Cook C, Khan S, Davies J, Collet C, Bruyne B, Channon K, Banning A, Keeble T, De Maria GL, of the Oxford Acute Myocardial Infarction (OxAMI) study investigator o

Original Research

10.4244/EIJ-D-25-00769 • Mar 2, 2026

Safety and effectiveness of drug-coated devices in chronic limb-threatening ischaemia: a nationwide analysis

Dubosq-Lebaz M, Li S, Gouëffic Y, Lee H, Kim J, Sobocinski J, Behrendt C, Iida O, Secemsky E

Flashlight

10.4244/EIJ-D-24-00661 • Mar 2, 2026

Percutaneous access and closure in transcarotid aortic valve implantation using a collagen vascular plug

Parma R, Gocol R, Morkisz L, van Mieghem N, Modine T, Hudziak D

Snapshot

• Mar 2, 2026

An expert review on non-invasive diagnosis of coronary dysfunction; excimer laser coronary atherectomy PCI; outcomes of intravascular imaging-guided PCI in ACS patients; absolute coronary flow after PCI; chronic limb-threatening ischaemia outcomes with drug-coated devices; percutaneous closure for transcarotid TAVI; and more

free

Intro editorial

Feb 16, 2026

A State-of-the-Art on adjunctive pharmacological strategies for residual risk; a consensus statement on day-case PCI; aspirin discontinuation timing in ACS; 7-year outcomes in COMPARE-ABSORB; the PINNACLE-I trial; a novel spacer for tricuspid regurgitation treatment; news from PCR; and more

Capodanno D

free

Viewpoint

Feb 16, 2026

PCR: a new era dawns

Prendergast B

free

Editorial

10.4244/EIJ-D-25-01330 • Feb 16, 2026

Aspirin discontinuation after ACS: timing the transition to ticagrelor monotherapy

Gragnano F, Calabrò P

free

Editorial

10.4244/EIJ-D-25-01331 • Feb 16, 2026

Will the dream of "leave nothing behind" remain a utopia if we forget to optimise the systemic medical therapy?

Wykrzykowska J, Kraak R

free

State-of-the-Art

10.4244/EIJ-D-25-00598 • Feb 16, 2026

Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation

Oshima A, Serruys P, Garg S, McEvoy J, Wood D, Doenst T, Taggart D, Puskas J, Shajahan A, Sharif F, Miyashita K, Tobe A, Tsai T, Revaiah P, Dunne F, Mehran R, Budoff M, Kastelein J, Stroes E, Khamis R, Koenig W, Onuma Y

free